In a large retrospective study, 2000 patients with NSCLC, melanoma, and RCC treated with nivolumab therapy were enrolled, and the results showed a negative relation between elevated IL‐8 serum levels with OS. This evidence concerns the gene CXCL8 and non-small cell lung carcinoma.